The mechanistic studies found that LINC01537 stabilizes RIPK4 by reducing the binding of RIPK4 to TRIM25, and reducing its ubiquitination degradation, thereby enhancing the NF-κB signaling pathway to promote GC metastasis and tumorigenesis. Here, RIPK4 is linked to gastric cancer.